Research & Publications – Macular Degeneration

Fumi Gomi MD , Masahito Ohji MD, Kaori Sayanagi MD.F One-Year Outcomes of Photodynamic Therapy in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in Japanese Patients. Ophthalmology Volume 115, Issue 1, January 2008, Pages 141-146

Andrew N. Antoszyk , Lisa Tuomi. Ranibizumab Combined With Verteporfin Photodynamic Therapy in Neovascular Age-related Macular Degeneration (FOCUS): Year 2 Results. American Journal of Ophthalmology. Volume 145, Issue 5, May 2008, Pages 862-874.

G Weigert, S Michels, S Sacu Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical studyBr J Ophthalmol 2008;92:356-360

Bashshur, Ziad F MD; Schakal, Alex R MD. Ranibizumab Monotherapy Versus Single-Session Verteporfin Photodynamic Therapy Combined With As-Needed Ranibizumab Treatment for the Management of Neovascular Age-Related Macular Degeneration. Retina: April 2011 – Volume 31 – Issue 4 – pp 636-644

Richard Wormald, Jennifer Evans. Photodynamic therapy for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD002030.

Jeffrey S. Heier, MD; David S. Boyer, MD. Ranibizumab Combined With Verteporfin Photodynamic Therapy in Neovascular Age-Related Macular Degeneration. Archives of Ophthamology Vol. 124 No. 11, November 2006

Peter K. Kaiser MD  and Registry of Visudyne AMD Therapy Writing Committee. Verteporfin Photodynamic Therapy Combined With Intravitreal Bevacizumab for Neovascular Age-Related Macular Degeneration. Ophthalmology Volume 116, Issue 4, April 2009, Pages 747-755.

Eric Chen, David M Brown, Tien P Wong. Lucentis® using Visudyne® study: determining the threshold-dose fluence of verteporfin photodynamic therapy combined with intravitreal ranibizumab for exudative macular degeneration. Clin Ophthalmol. 2010; 4: 1073–1079.

M A Brantley Jr, S L Edelstein, J M King. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy. Eye (2009) 23, 626–631

SMITH, BRADLEY T. MD; DHALLA, MANDEEP S. MD. Intravitreal Injection of Bevacizumab Combined With Verteporfin Photodynamic Therapy for Choroidal Neovascularization in Age-Related Macular Degeneration. Retina: May 2008 – Volume 28 – Issue 5 – pp 675-681

Leave a comment

You must be logged in to post a comment.